Register Speakers 

SUNDAY, June 5, 2022
Pre-Con #1: Arthropods and Occupational Health Issues (8 am – 12 pm)
Aristea Lubar, University of California, San Diego
Robyn Raban, PhD, University of California, San Diego
Maureen Thompson, BSN, RN, COHN-S, RBP, Emory University

Beyond Containment: Risk Analysis of Malaria in Mosquito Models
Aristea Lubar, University of California, San Diego
Malaria is both a classical and continual public health risk, and as a target of ongoing global health eradication efforts, represents an expanding area of research. Robust malaria research frequently involves the use of this parasite in live mosquito models. Expanding the use of infectious agents from the petri dish to the arthropod vector increases the risk of exposure to personnel, the community, and the environment. Conducting malaria research in mosquito models frequently involves detailed procedures, time sensitivity, and manipulations not always conducive to risk reduction. Further confounding matters, tried and tested engineering controls, safety equipment, and personal protective gear, such as are standard for microbiology, do not always translate well when working with arthropods. Here we discuss common, high-risk procedures involved when working with human malaria in the mosquito model, exposure risks at all life stages of parasite and arthropod, and risk mitigation practices, which may not always fit the ideal biosafety mold.


Case Study: Post Exposure Treatment for Malaria; Maureen Thompson, BSN, RN, COHN-S, RBP


Emerging Technologies in Arthropod-Borne Disease Control
Robyn Raban, PhD, University of California, San Diego
Due to the urgent need for new prevention technologies for important arthropod-borne diseases, such as malaria, dengue, and Zika, and the recent technological advancements that have made genome engineering more efficient and accessible to the research community, there has been rapid development of potentially transformative technologies in arthropod research. This talk will give an overview of emerging technologies in the field of arthropod-borne disease research, including technologies to engineer disease resistant mosquitoes, gene drive technologies to rapidly facilitate the spread of disease resistance into a population and technologies to kill mosquito populations. It will also highlight the risks associated with these technologies and the current approaches to mitigate these risks as well as further directions and concerns in the field.


Case Study: Zika laboratory Infection; Maureen Thompson, BSN, RN, COHN-S, RBP


Pre-Con #2: Designing and Implementing Occupational health Programs (1 pm – 5 pm)
Amy Behrman, MD, FACP, FACOEM, University of Pennsylvania
Philip Harbor, MD, MPH, University of Arizona
Marcia Isakari, MD, MPH, MRO, University of California, San Diego

Designing and Implementing Occupational health Programs
In this case study-based program, speakers will address regulatory,
hazardous and hazardous control practices.

Institutions of all sizes need to have a robust occupational health program to prevent and treat exposures, as well as to meet the inspection requirements of outside agencies. This class will begin by providing an overview of the regulations, workplace hazards, and hazard control practices that need to be considered in program design. Three specific protective programs will then be presented and discussed in small group sessions – respiratory protection, post-exposure management using viral vectors as an example, and surveillance for animal allergies. Differences in approaches for smaller colleges, large research universities, healthcare systems and freestanding/corporate research organizations will be explored. The three instructors will share insights gained from years of leading occupational health departments, as well as in writing a soon-to-be-published book, Occupational Health for Higher Education and Research Institutions: A Guide for Employee Health and Student Health Programs, Philip Harber, MD, MPH, Editor



Tired of COVID? There is more to worry about! The June 2022 Occupational Health Colloquium will move beyond SARS CoV2.

Deep dives will be taken into the following topics:


Update on SARS CoV2 Virus, Vaccine, Variants, Therapeutics

Mental Health Issues In the Workplace

Working with Research Animals –  Covid, Rabies, AALAC Inspection Discoveries

Novel Genetic Technologies

Update on Immunization

Special Session:   

Who Did What?  In this three-act dramatization performed by brave planning team members, a case is followed from initial exposure to lessons learned.  A group consisting of both medical and biosafety professionals will explore questions to ask an employee after an exposure, how to manage the exposure, the investigation of the incident, and the follow-up by the IBC, IACUC, EHS, PI, and Occupational Health physicians and nurses. Pathways for communication and collaboration between disciplines, as well as tips for overcoming pit falls and roadblocks, will be explored. Based on years of experience, the team will share thoughts and experiences on the impact of culture and accountability on a successful Occupational Health program. Participants will be able to join in and discuss what they wish they knew as they moved through different stages of their careers. What key lessons would you share with colleagues? What recommendations do you have for communicating biological hazards to those working with an agent?


Speakers will be announced soon!